A citation-based method for searching scientific literature

Anjelica Hodgson, Gulisa Turashvili. Front Oncol 2020
Times Cited: 8







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
322
37

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
25

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.
Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Eric Hahnen, Jan Hauke, Britta Bluemcke, Verena Zarghooni, Natalie Herold, Nina Ditsch, Marion Kiechle,[...]. J Med Genet 2016
77
25

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours.
Liliana D Ordonez, Trevor Hay, Robert McEwen, Urszula M Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo,[...]. Oncotarget 2019
7
28

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.
Eun-Ha Lee, Sue K Park, Boyoung Park, Sung-Won Kim, Min Hyuk Lee, Sei Hyun Ahn, Byung Ho Son, Keun-Young Yoo, Daehee Kang. Breast Cancer Res Treat 2010
57
25

Playing the end game: DNA double-strand break repair pathway choice.
J Ross Chapman, Martin R G Taylor, Simon J Boulton. Mol Cell 2012
941
25

BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance.
Yifan Wang, Andrea J Bernhardy, Joseph Nacson, John J Krais, Yin-Fei Tan, Emmanuelle Nicolas, Marc R Radke, Elizabeth Handorf, Alba Llop-Guevara, Judith Balmaña,[...]. Nat Commun 2019
19
25

Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations.
Ainhoa Madariaga, Stephanie Lheureux, Amit M Oza. Cancers (Basel) 2019
30
25

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
304
25

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
602
25

Molecular Trajectory of BRCA1 and BRCA2 Mutations.
Yuichiro Hatano, Maho Tamada, Mikiko Matsuo, Akira Hara. Front Oncol 2020
19
12

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen. Front Oncol 2020
10
12


Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations.
Athanasios Pouptsis, Leyla Swafe, Maneesha Patwardhan, Chara Stavraka. Front Oncol 2020
5
20

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.
Ana Peixoto, Pedro Pinto, Joana Guerra, Manuela Pinheiro, Catarina Santos, Carla Pinto, Rui Santos, Carla Escudeiro, Carla Bartosch, Rita Canário,[...]. Front Oncol 2020
3
33

PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials.
Yizi Wang, Fang Ren, Zixuan Song, Xiaoying Wang, Chiyuan Zhang, Ling Ouyang. Front Oncol 2020
2
50

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Hsiao-Mei Lu, Shuwei Li, Mary Helen Black, Shela Lee, Robert Hoiness, Sitao Wu, Wenbo Mu, Robert Huether, Jefferey Chen, Srijani Sridhar,[...]. JAMA Oncol 2019
70
12

BRCA1 and Its Network of Interacting Partners.
Charita M Christou, Kyriacos Kyriacou. Biology (Basel) 2013
24
12



Identification of BRCA1-IRIS, a BRCA1 locus product.
Wael M ElShamy, David M Livingston. Nat Cell Biol 2004
75
12

Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production.
Zhi Shi, Wei-Min Yang, Li-Pai Chen, Dong-Hua Yang, Qi Zhou, Jin Zhu, Jun-Jiang Chen, Ruo-Chun Huang, Zhe-Sheng Chen, Ruo-Pan Huang. Breast Cancer Res Treat 2012
70
12

Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids.
Jeanine M L Roodhart, Laura G M Daenen, Edwin C A Stigter, Henk-Jan Prins, Johan Gerrits, Julia M Houthuijzen, Marije G Gerritsen, Henk S Schipper, Marieke J G Backer, Miranda van Amersfoort,[...]. Cancer Cell 2011
213
12

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
Gemma Molyneux, Felipe C Geyer, Fiona-Ann Magnay, Afshan McCarthy, Howard Kendrick, Rachael Natrajan, Alan Mackay, Anita Grigoriadis, Andrew Tutt, Alan Ashworth,[...]. Cell Stem Cell 2010
462
12

Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
Frank Weber, Lei Shen, Koichi Fukino, Attila Patocs, George L Mutter, Trinidad Caldes, Charis Eng. Am J Hum Genet 2006
70
12

FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response.
Jenny Xie, Min Peng, Shawna Guillemette, Steven Quan, Stephanie Maniatis, Yuliang Wu, Aditya Venkatesh, Scott A Shaffer, Robert M Brosh, Sharon B Cantor. PLoS Genet 2012
34
12

Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production.
Ahmed F Salem, Anthony Howell, Marina Sartini, Federica Sotgia, Michael P Lisanti. Cell Cycle 2012
31
12

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
701
12

Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Baha Zengel, Ulkem Yararbas, Ali Duran, Adam Uslu, Nukhet Elıyatkın, Mehmet Ali Demırkıran, Fevzi Cengiz, Cenk Şimşek, Hakan Postacı, Enver Vardar,[...]. Breast Cancer 2015
30
12

VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.
Concetta Saponaro, Andrea Malfettone, Girolamo Ranieri, Katia Danza, Giovanni Simone, Angelo Paradiso, Anita Mangia. PLoS One 2013
51
12

Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells.
L Kucerova, M Kovacovicova, S Polak, M Bohac, J Fedeles, D Palencar, M Matuskova. Neoplasma 2011
36
12

Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer.
Yeuan Ting Lee, Yi Jer Tan, Marco Falasca, Chern Ein Oon. Cancers (Basel) 2020
7
14

BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
Yaning Zhu, Jian Wu, Chengwan Zhang, Suan Sun, Jian Zhang, Wenjie Liu, Jian Huang, Zhihong Zhang. Oncotarget 2016
24
12

Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients.
Jean-Sébastien Milanese, Chabane Tibiche, Jinfeng Zou, Zhigang Meng, Andre Nantel, Simon Drouin, Richard Marcotte, Edwin Wang. NPJ Precis Oncol 2019
11
12

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy.
Chao Liu, Sriganesh Srihari, Kim-Anh Lê Cao, Georgia Chenevix-Trench, Peter T Simpson, Mark A Ragan, Kum Kum Khanna. Nucleic Acids Res 2014
50
12

Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Yun Song, William T Barry, Davinia S Seah, Nadine M Tung, Judy E Garber, Nancy U Lin. Cancer 2020
21
12

Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
134
12

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
828
12

The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Junran Zhang, Simon N Powell. Mol Cancer Res 2005
138
12

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Paul J Chuba, Merlin R Hamre, Johnny Yap, Richard K Severson, David Lucas, Falah Shamsa, Amr Aref. J Clin Oncol 2005
140
12

Epithelial-mesenchymal transition in development and cancer.
Douglas S Micalizzi, Heide L Ford. Future Oncol 2009
100
12

Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF).
Sreelatha K Hemalatha, Satheesh Kumar Sengodan, Revathy Nadhan, Jithin Dev, Reshma R Sushama, Veena Somasundaram, Ratheeshkumar Thankappan, Arathi Rajan, Neetha Rajan Latha, Geetu Rose Varghese,[...]. Sci Rep 2018
7
14

Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Sagar Ghosh, Yunzhe Lu, Adam Katz, Yanfen Hu, Rong Li. Am J Physiol Endocrinol Metab 2007
40
12

Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation.
Alessandro Gardini, David Baillat, Matteo Cesaroni, Ramin Shiekhattar. EMBO J 2014
29
12

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.
Ugo De Giorgi, Michal Mego, Emanuela Scarpi, Antonio Giordano, Mario Giuliano, Vicente Valero, Ricardo H Alvarez, Naoto T Ueno, Massimo Cristofanilli, James M Reuben. Ther Adv Med Oncol 2019
10
12

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
Jana Plava, Marina Cihova, Monika Burikova, Miroslava Matuskova, Lucia Kucerova, Svetlana Miklikova. Mol Cancer 2019
56
12

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.
Debbie Liao, Courtney Corle, Tiffany N Seagroves, Randall S Johnson. Cancer Res 2007
260
12

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
431
12

Role of estrogen receptor signaling in breast cancer metastasis.
Sudipa Saha Roy, Ratna K Vadlamudi. Int J Breast Cancer 2012
84
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.